FDA Approves Unknown Drug — SINOTHERAPEUTICS INC

# FDA Approves ANDA for SinoTherapeutics Inc SinoTherapeutics Inc has received FDA approval for ANDA220454, marking the company's entry into the generic drug market and positioning it to capture market share in an established therapeutic category. The approval strengthens SinoTherapeutics' portfolio and enables the manufacturer to compete in the competitive generic pharmaceuticals sector, potentially benefiting patients through increased treatment accessibility and price competition.